Furthermore, a study on 20 pregnant insulin-treated GDM women (GDMA2) has shown that TXNIP and TRX expression were increased in maternal serum and placental tissue and decreased in umbilical cord blood compared to healthy individuals [100]. The gene discussed is TXN; the disease is gestational diabetes.